Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$3.72 - $5.35 $1,674 - $2,407
-450 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$3.23 - $4.3 $12,920 - $17,200
-4,000 Reduced 89.89%
450 $1,000
Q2 2020

Aug 13, 2020

BUY
$3.31 - $6.54 $1,489 - $2,943
450 Added 11.25%
4,450 $15,000
Q2 2019

Aug 16, 2019

BUY
$5.4 - $15.5 $21,600 - $62,000
4,000 New
4,000 $54,000

Others Institutions Holding ZYNE

About Zynerba Pharmaceuticals, Inc.


  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.